Roth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6

Benzinga · 1d ago
Roth Capital analyst Kyle Bauser initiates coverage on Apyx Medical (NASDAQ:APYX) with a Buy rating and announces Price Target of $6.